Exploring Biosimilars as a Drug Patent Strategy

Biologic drugs are far more complex than traditional “small molecule” drugs Generic drugs as we know them differ from biosimilars, which are designed to be less costly alternatives to branded biologic drugs.… The post Exploring Biosimilars as a Drug Patent Strategy appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: